Reduced ovarian glyoxalase-I activity by dietary glycotoxins and androgen excess: A causative link to polycystic ovarian syndrome

Molecular Medicine

Volumn 18, Issue 8, 2012, Pages 1183-1189

  Kandaraki, Eleni ^a   Chatzigeorgiou, Antonis ^a   Piperi, Christina ^a   Palioura, Eleni ^a   Palimeri, Sotiria ^a   Korkolopoulou, Penelope ^a   Koutsilieris, Michael ^a   Papavassiliou, Athanasios G ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED GLYCATION END PRODUCT; ANDROGEN; ESTRADIOL; GLYCOTOXIN; LACTOYLGLUTATHIONE LYASE; PROGESTERONE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME ACTIVITY; ENZYME MODIFICATION; FEMALE; GRANULOSA CELL; NONHUMAN; OVARY POLYCYSTIC DISEASE; PREPUBERTY; PRIORITY JOURNAL; RAT; REGULATORY MECHANISM; WEIGHT GAIN;

ANDROGENS; ANIMALS; DIET; ESTRADIOL; FEMALE; GLYCOSYLATION END PRODUCTS, ADVANCED; HUMANS; IMMUNOHISTOCHEMISTRY; LACTOYLGLUTATHIONE LYASE; OVARIAN FOLLICLE; OVARY; POLYCYSTIC OVARY SYNDROME; RATS; RATS, WISTAR; RECEPTORS, PROGESTERONE; TESTOSTERONE;

EID: 84867606007     PISSN: 10761551     EISSN: None     Source Type: Journal    
DOI: 10.2119/molmed.2012.00293     Document Type: Article

References (33)

1. Thornalley PJ. (1990) The glyoxalase system: new developments towards functional characterization of a metabolic pathway fundamental to biological life. Biochem. J. 269:1-11.
2. Principato GB, Locci P, Rosi G, Talesa V, Giovannini E. (1983) Activity changes of glyoxalases I-II and glutathione reductase in regenerating rat liver. Biochem. Int. 6:249-55.
3. Kalia S, Pal S, Guha-Mukherjee S. (1998) Activation of glyoxalase I during the cell division cycle and its homology with auxin regulated genes. Plant Sci. 132:55-62.
4. Thornalley PJ. (2008) Protein and nucleotide damage by glyoxal and methylglyoxal in physiological systems: role in ageing and disease. Drug Metabol. Drug Interact. 23:125-50.
5. Thornalley PJ. (2003) Glyoxalase I-structure, function and a critical role in the enzymatic defence against glycation. Biochem. Soc. Trans. 31:1343-8.
6. Ratliff DM, Vander Jagt DJ, Eaton RP, Vander Jagt DL. (1996) Increased levels of methylglyoxalmetabolizing enzymes in mononuclear and polymorphonuclear cells from insulin-dependent diabetic patients with diabetic complications: aldose reductase, glyoxalase I, and glyoxalase II: a clinical research center study. J. Clin. Endocrinol. Metab. 81:488-92.
7. Kuhla B, et al. (2007) Age-and stage-dependent glyoxalase I expression and its activity in normal and Alzheimer's disease brains. Neurobiol. Aging. 28:29-41.
8. Ayoub F, Zaman M, Thornalley P, Masters J. (1993) Glyoxalase activities in human tumour cell lines in vitro. Anticancer Res. 13:151-5.
9. Brouwers O, et al. (2011) Overexpression of glyoxalase-I reduces hyperglycemia-induced levels of advanced glycation end products and oxidative stress in diabetic rats. J. Biol. Chem. 286:1374-80.
10. Kim KM, Kim YS, Jung DH, Lee J, Kim JS. (2012) Increased glyoxalase I levels inhibit accumulation of oxidative stress and an advanced glycation end product in mouse mesangial cells cultured in high glucose. Exp. Cell Res. 318:152-9.
11. Tatone C, et al. (2010) Female reproductive dysfunction during ageing: role of methylglyoxal in the formation of advanced glycation endproducts in ovaries of reproductively-aged mice. J. Biol. Regul. Homeost. Agents. 24:63-72.
12. Niwa T. (2006) Mass spectrometry for the study of protein glycation in disease. Mass Spectrom. Rev. 25:713-23.
13. Semba RD, Nicklett EJ, Ferrucci L. (2010) Does accumulation of advanced glycation end products contribute to the aging phenotype? J. Gerontol. A Biol. Sci. Med. Sci. 65:963-75.
14. Goh SY, Cooper ME. (2008) Clinical review: the role of advanced glycation end products in progression and complications of diabetes. J. Clin. Endocrinol. Metab. 93:1143-52.
15. Goldberg T, et al. (2004) Advanced glycoxidation end products in commonly consumed foods. J. Am. Diet Assoc. 104:1287-91.
16. de Assis AM, et al. (2009) High fat and highly thermolyzed fat diets promote insulin resistance and increase DNA damage in rats. Exp. Biol. Med. (Maywood). 234:1296-304.
17. Diamanti-Kandarakis E, et al. (2007) Accumulation of dietary glycotoxins in the reproductive system of normal female rats. J. Mol. Med. 85:1413-20.
18. Diamanti-Kandarakis E, et al. (2007) Immunohistochemical localization of advanced glycation end-products (AGEs) and their receptor (RAGE) in polycystic and normal ovaries. Histochem. Cell Biol. 127:581-9.
19. Mukhopadhyay S, Mukherjee TK. (2005) Bridging advanced glycation end product, receptor for advanced glycation end product and nitric oxide with hormonal replacement/estrogen therapy in healthy versus diabetic postmenopausal women: a perspective. Biochim. Biophys. Acta. 1745:145-55.
20. Kaya C, et al. (2009) Advanced oxidation protein products are increased in women with polycystic ovary syndrome: relationship with traditional and nontraditional cardiovascular risk factors in patients with polycystic ovary syndrome. Fertil. Steril. 92:1372-7.
21. Diamanti-Kandarakis E, Piperi C, Kalofoutis A, Creatsas G. (2005) Increased levels of serum advanced glycation end-products in women with polycystic ovary syndrome. Clin. Endocrinol. (Oxf). 62:37-43.
22. Antognelli C, et al. (2007) Alteration of glyoxalase genes expression in response to testosterone in LNCaP and PC3 human prostate cancer cells. Cancer Biol. Ther. 6:1880-8.
23. Rulli A, et al. (2006) A possible regulatory role of 17beta-estradiol and tamoxifen on glyoxalase I and glyoxalase II genes expression in MCF7 and BT20 human breast cancer cells. Breast Cancer Res. Treat. 96:187-96.
24. Diamanti-Kandarakis E. (2008) Polycystic ovarian syndrome: pathophysiology, molecular aspects and clinical implications. Expert Rev. Mol. Med. 10:e3.
25. Mannerås L, et al. (2007) A new rat model exhibiting both ovarian and metabolic characteristics of polycystic ovary syndrome. Endocrinology. 148:3781-91.
26. Birkenmeier G, et al. (2010) Posttranslational modification of human glyoxalase 1 indicates redox-dependent regulation. PLoS One. 5:e10399.
27. Tatone C, et al. (2011) Evidence that carbonyl stress by methylglyoxal exposure induces DNA damage and spindle aberrations, affects mitochondrial integrity in mammalian oocytes and contributes to oocyte ageing. Hum. Reprod. 26:1843-59.
28. de Arriba SG, et al. (2007) Methylglyoxal impairs glucose metabolism and leads to energy depletion in neuronal cells-protection by carbonyl scavengers. Neurobiol. Aging. 28:1044-50.
29. Lee HJ, Howell SK, Sanford RJ, Beisswenger PJ. (2005) Methylglyoxal can modify GAPDH activity and structure. Ann. N. Y. Acad. Sci. 1043:135-45.
30. Jinno M, et al. (2011) Advanced glycation endproducts accumulation compromises embryonic development and achievement of pregnancy by assisted reproductive technology. Hum. Reprod. 26:604-10.
31. Zheng F, et al. (2002) Prevention of diabetic nephropathy in mice by a diet low in glycoxidation products. Diabetes Metab. Res. Rev. 18:224-37.
32. Feng JX, et al. (2007) Restricted intake of dietary advanced glycation end products retards renal progression in the remnant kidney model. Kidney Int. 71:901-11.
33. Peppa M, et al. (2003) Adverse effects of dietary glycotoxins on wound healing in genetically diabetic mice. Diabetes. 52:2805-13.